For Q4 2025, AMN Healthcare generated revenue of 748225000, up 2% year over year. The company reported a GAAP net loss of -7696000, or -0.20 per diluted share, while adjusted diluted EPS was 0.22. Adjusted EBITDA was 54483000 with a margin of 7.3%.

AMN Healthcare experienced a challenging second quarter in 2025, with consolidated revenue decreasing by 11% year-over-year to $658 million and a GAAP net loss of $116.2 million, largely driven by $128 million in non-cash goodwill and intangible asset impairment charges. Despite the GAAP loss, adjusted diluted EPS was $0.30, and adjusted EBITDA was $58.3 million, both showing significant year-over-year declines. The company noted that allied staffing performed well, exceeding projections, and strong cash flow from operations allowed for debt reduction.

AMN Healthcare reported first quarter 2025 revenue of $690 million, a 16% decrease year-over-year. The company posted a GAAP net loss of $1.1 million and adjusted diluted EPS of $0.45. Results were above the high end of guidance, benefiting from growth in client patient volumes and market adoption of tech-enabled solutions.

AMN Healthcare Services, Inc. exceeded expectations in Q4 2024, driven by better labor disruption and core nurse and allied staffing revenue. The company reported a net loss due to a non-cash goodwill impairment, but saw strong cash flow from operations and reduced debt.

AMN Healthcare announced its third quarter 2024 financial results, with consolidated revenue of $688 million. GAAP EPS was $0.18, and adjusted EPS was $0.61. The company is innovating with clients and healthcare partners to optimize their workforce.

AMN Healthcare reported a second-quarter revenue of $741 million, a 25% decrease year-over-year. GAAP EPS was $0.42, and adjusted EPS was $0.98. The company is seeing promising signs of improvement in the travel nurse market.

AMN Healthcare reported a Q1 2024 revenue of $821 million, a 27% decrease year-over-year. GAAP EPS was $0.45, and adjusted EPS was $0.97. The company is managing expenses and capital spending amidst lower travel nurse demand while focusing on long-term objectives.

AMN Healthcare's Q4 2023 revenue was $818 million, a 27% decrease year-over-year and 4% lower than the prior quarter. GAAP EPS was $0.33, and adjusted EPS was $1.32. The company is focused on technology-centric total talent solutions and consolidating businesses under the One AMN platform.

AMN Healthcare's Q3 2023 revenue was $853.5 million, a 25% decrease year-over-year. Net income was $53 million, or $1.39 per diluted share, compared to $92 million, or $2.10 per diluted share, in Q3 2022. Adjusted diluted EPS was $1.97 compared to $2.57 in the same quarter last year.

AMN Healthcare reported Q2 2023 consolidated revenue of $991.3 million, a 31% decrease from the prior year and 12% lower than the prior quarter. GAAP EPS was $1.55, and adjusted EPS was $2.38. The company is focused on technology enablement and strategic talent solutions.

AMN Healthcare announced its first quarter 2023 financial results with a revenue of $1.126 billion, a 27% decrease from prior year. GAAP EPS was $2.02 and adjusted EPS was $2.49. The company is focusing on sustainable workforce solutions and investing in technology enhancements.

AMN Healthcare announced its fourth quarter and full year 2022 financial results. The company's Q4 revenue was $1.126 billion, a 17% decrease over prior year. Net income was $82 million, or $1.88 per diluted share, compared with $116 million, or $2.42 per diluted share, in the same quarter last year. Adjusted diluted EPS was $2.48 compared with $2.95 in the year-ago quarter.

AMN Healthcare reported a strong third quarter in 2022, with revenue reaching $1.139 billion, a 30% increase year-over-year. GAAP EPS was $2.10, and adjusted EPS was $2.57. The company is transitioning leadership with Cary Grace taking over as CEO.

AMN Healthcare announced strong second quarter 2022 results with revenue of $1.427 billion, a 66% increase over the prior year. GAAP EPS was $2.77, and adjusted EPS was $3.31. The company's performance was driven by robust demand and strong market conditions.

AMN Healthcare announced record first quarter 2022 results with revenue of $1.553 billion, a 75% increase over the prior year. GAAP EPS was $3.09, and adjusted EPS was $3.49. The company experienced strong demand across its nursing, allied, locum tenens, and other businesses.

AMN Healthcare announced Q4 2021 results with revenue of $1.36 billion, a 116% increase over the prior year. GAAP EPS was $2.42, and adjusted EPS was $2.95. Demand for workforce staffing and technology solutions grew, and investments in digital platforms improved clinician and client experience.

AMN Healthcare's Q3 2021 revenue reached $878 million, a 59% increase year-over-year. GAAP EPS was $1.54, and adjusted EPS was $1.73. The company is investing in its team and solutions to meet the ongoing healthcare labor shortage.

AMN Healthcare reported a strong second quarter in 2021, with revenue of $857 million, a 41% increase over the prior year. GAAP EPS was $1.39, and adjusted EPS was $1.64. The company benefited from increased healthcare utilization and a tight labor market, leading to record high demand.

AMN Healthcare's first quarter 2021 revenue reached $886 million, a 47% increase year-over-year, with GAAP EPS of $1.47 and adjusted EPS of $1.70. The company experienced growth across all reportable segments, driven primarily by nurse and allied staffing, language services, and vendor management systems.

AMN Healthcare announced Q4 2020 results with revenue of $631 million, up 8% year-over-year. GAAP EPS was $0.19, and adjusted EPS was $1.00. The company experienced record demand for nurse and allied staffing and significant growth in locum tenens and interim leadership during the quarter. All three reportable segments exceeded revenue guidance.

AMN Healthcare reported Q3 2020 revenue of $552 million, a 3% decrease year-over-year. While nurse staffing showed strength due to the COVID-19 pandemic, other service lines experienced continued impacts. Net income and adjusted EBITDA both increased by 11% year-over-year.

AMN Healthcare reported a 14% increase in revenue to $608 million for Q2 2020. The company's adjusted EPS was $0.83, and they reduced debt by $127 million, achieving a leverage ratio of 2.7 to 1.

AMN Healthcare reported Q1 2020 revenue of $602 million, a 13% increase year-over-year. GAAP EPS was $0.27, while adjusted EPS was $0.79. The company experienced growth in most business lines during the first two months of the year, but the COVID-19 pandemic negatively impacted several divisions in March. The acquisition of Stratus Video contributed $14 million in revenue.

AMN Healthcare announced strong Q4 2019 results, with revenue reaching $587 million, an 11% increase year-over-year. The Nurse and Allied Solutions segment drove growth, supported by labor disruption events and rapid response staffing. Adjusted EPS was $0.85, reflecting a 5% increase from the prior year.